Table 6.

Predicted cumulative total and CRPC-specific health care costs (adjusted)

Cohort	Cumulative years
	1	1–2	1–3	1–4	1–5	1–6
Adjusted total health care costs (US$)
Urology cohort (ref.)	31,791.58	49,463.35	64,476.63	72,970.69	83,089.42	86,706.26
Oncology with chemotherapy	54,305.81‡	92,096.22†	123,586.28‡	150,633.48‡	159,824.79‡	168,793.50‡
Oncology without chemotherapy	30,894.37	54,351.70	72,104.95	89,200.67†	103,629.01*	114,179.69†
Adjusted CRPC-specific costs (US$)
Urology cohort (ref.)	10,666.83	16,259.84	20,028.80	22,226.95	23,692.21	25,081.09
Oncology with chemotherapy	26,042.74‡	41,259.20‡	53,476.65‡	63,464.28‡	66,685.71‡	68,286.20‡
Oncology without chemotherapy	9,648.83	16,216.14	20,655.64	24,067.06	29,942.43	32,927.43

Notes:

^*P < 0.05;

^†P < 0.01;

^‡P < 0.001.

Abbreviations: CRPC, castration-resistant prostate cancer; ref, reference group.